Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?

10.1016/j.pharmthera.2022.108153

Saved in:

Bibliographic Details
Main Authors:	Heng, CKM, Gilad, N, Darlyuk-Saadon, I, Wong, WSF, Engelberg, D
Other Authors:	MICROBIOLOGY AND IMMUNOLOGY
Format:	Review
Published:	Elsevier BV 2022
Subjects:	Chronic inflammation Hsp27 MK2 Mitogen-activated protein kinase Animals Down-Regulation Humans Inflammation Inflammation Mediators Mice Mitogen-Activated Protein Kinase 14
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/229044
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-229044
record_format	dspace
spelling	sg-nus-scholar.10635-2290442024-04-04T04:00:29Z Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy? Heng, CKM Gilad, N Darlyuk-Saadon, I Wong, WSF Engelberg, D MICROBIOLOGY AND IMMUNOLOGY PHARMACOLOGY Chronic inflammation Hsp27 MK2 Mitogen-activated protein kinase Animals Down-Regulation Humans Inflammation Inflammation Mediators Mice Mitogen-Activated Protein Kinase 14 10.1016/j.pharmthera.2022.108153 Pharmacology and Therapeutics 235 108153- 2022-07-22T02:05:20Z 2022-07-22T02:05:20Z 2022-07-01 2022-07-17T03:42:57Z Review Heng, CKM, Gilad, N, Darlyuk-Saadon, I, Wong, WSF, Engelberg, D (2022-07-01). Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?. Pharmacology and Therapeutics 235 : 108153-. ScholarBank@NUS Repository. https://doi.org/10.1016/j.pharmthera.2022.108153 01637258 1879016X https://scholarbank.nus.edu.sg/handle/10635/229044 Elsevier BV Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Chronic inflammation Hsp27 MK2 Mitogen-activated protein kinase Animals Down-Regulation Humans Inflammation Inflammation Mediators Mice Mitogen-Activated Protein Kinase 14
spellingShingle	Chronic inflammation Hsp27 MK2 Mitogen-activated protein kinase Animals Down-Regulation Humans Inflammation Inflammation Mediators Mice Mitogen-Activated Protein Kinase 14 Heng, CKM Gilad, N Darlyuk-Saadon, I Wong, WSF Engelberg, D Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
description	10.1016/j.pharmthera.2022.108153
author2	MICROBIOLOGY AND IMMUNOLOGY
author_facet	MICROBIOLOGY AND IMMUNOLOGY Heng, CKM Gilad, N Darlyuk-Saadon, I Wong, WSF Engelberg, D
format	Review
author	Heng, CKM Gilad, N Darlyuk-Saadon, I Wong, WSF Engelberg, D
author_sort	Heng, CKM
title	Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
title_short	Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
title_full	Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
title_fullStr	Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
title_full_unstemmed	Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
title_sort	targeting the p38α pathway in chronic inflammatory diseases: could activation, not inhibition, be the appropriate therapeutic strategy?
publisher	Elsevier BV
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/229044
_version_	1800915507120963584

Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?

Similar Items